Clonal Analysis of Human Recurrent Superficial Bladder Cancer by Immunohistochemistry of P53 and Retinoblastoma Proteins
- 1 November 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 156 (5) , 1846-1849
- https://doi.org/10.1016/s0022-5347(01)65550-2
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Metachronous multifocal development of urothelial cancers by intraluminal seedingThe Lancet, 1993
- Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease ProgressionJNCI Journal of the National Cancer Institute, 1993
- A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaCell, 1992
- p53 function and dysfunctionCell, 1992
- Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder CancerJNCI Journal of the National Cancer Institute, 1992
- p53, guardian of the genomeNature, 1992
- Clonal Origin of Bladder CancerNew England Journal of Medicine, 1992
- Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Molecular and Cellular Biology, 1988
- Superficial Bladder Tumors (Stage pTa, Grades 1 and 2): The Importance of Recurrence Pattern Following Initial ResectionJournal of Urology, 1986
- Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cellsCell, 1979